TPW
BHVN icon

Transatlantique Private Wealth’s Biohaven BHVN Stock Holding History

Transatlantique Private Wealth’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,726
Closed -$191K – 209
2025
Q3 		$191K Sell
12,726
-20
-0.2% -$291 0.06% 210
2025
Q2 		$180K Sell
12,746
-1,229
-9% -$21.9K 0.07% 214
2025
Q1 		$336K Buy
13,975
+544
+4% +$19.2K 0.13% 176
2024
Q4 		$502K Sell
13,431
-711
-5% -$33.2K 0.19% 145
2024
Q3 		$707K Buy
14,142
+6,435
+83% +$250K 0.27% 115
2024
Q2 		$268K Buy
7,707
+2,657
+53% +$105K 0.11% 178
2024
Q1 		$276K Buy
+5,050
New +$250K 0.12% 188

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Transatlantique Private Wealth's BHVN Position: Q4 2025 in Review

Transatlantique Private Wealth sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 12,726 shares — an estimated $191K sold.

Transatlantique Private Wealth first reported a position in BHVN in Q1 2024 and held it in 7 quarters. The position peaked at $707K in Q3 2024. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Transatlantique Private Wealth reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Transatlantique Private Wealth sold 12,726 Biohaven shares in Q4 2025, an estimated $191K.
  • Transatlantique Private Wealth first reported a position in Biohaven in Q1 2024 and held it in 7 quarters.
  • Transatlantique Private Wealth's Biohaven position peaked at $707K in Q3 2024.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.